BioSpace News Archive

BioMidwest

Alimera Sciences to Participate in Upcoming January 2022 Investor Conferences

Alimera Sciences, Inc. announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will participate in two investor conference events in January.

January 5, 2022
·
1 min read
Business

T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel

T-knife Therapeutics, Inc., a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, announced the appointment of Ronald Krasnow, J.D., who brings over thirty years of legal counsel and executive management experience to T-knife.

January 5, 2022
·
2 min read
Pharm Country

Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences

Agile Therapeutics, Inc., a women’s healthcare company, announced Chairman and Chief Executive Officer Al Altomari will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022, and at Biotech Showcase taking place January 10-12, 2022.

January 5, 2022
·
3 min read
Genetown

Werewolf Therapeutics to Present at the H.C. Wainwright Bioconnect Conference

Werewolf Therapeutics, Inc. announced that management will present at the H.C. Wainwright Bioconnect Conference, taking place virtually from January 10-13, 2022.

January 5, 2022
·
1 min read
Business

Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference

Sensus Healthcare, Inc. announces that it expects record sales for the fourth quarter of 2021, resulting in over $25 million in sales for the year, and positive EBITDA and net income for both the fourth quarter and full year.

January 5, 2022
·
6 min read
Pharm Country

Portage Biotech Announces Participation in January 2022 Investor Conferences

Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, announced that the Company will participate in three investor conferences during the month of January.

January 5, 2022
·
2 min read
Biotech Bay

Soleno Therapeutics to Participate in the LifeSci Partners 11th Annual Corporate Access Event

Soleno Therapeutics, Inc. announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in a panel discussion during the LifeSci Partners 11th Annual Corporate Access Event.

January 5, 2022
·
1 min read
Genetown

Avenge Bio Announces Closing of $45 Million Series A Financing

Avenge Bio, Inc., a biotechnology company developing the LOCOcyte™ immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, announced the closing of its Series A financing of $45 Million.

January 5, 2022
·
4 min read
Business

Hemab Therapeutics Appoints John Maraganore as Chair of Board of Directors and Welcomes New Additions to Board and Leadership Team

Hemab Therapeutics announced the appointment of John Maraganore, PhD, former founding CEO of Alnylam, as Board Chair, and Linda Bain, CFO of Codiak BioSciences, as Board member.

January 5, 2022
·
4 min read
Business

Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022

Catalent today announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the company’s next President and Chief Executive Officer, effective July 1, 2022.

January 5, 2022
·
7 min read